Designing of New Benzotriazole Analogs using Molecular Docking Studies Against Receptor 1EA1.Pdb & 1IYL.Pdb for Treatment of Fungal Infection
Abstract
Infectious diseases raise consciousness of our global liability and the aptitude of mankind to prepare medicinally significant molecules during the past century has lead to decrease in the mortality rate from numerous infectious diseases. Benzotriazole derivatives have showed activities like antibacterial, antifungal, antiviral, antiprotozoal and anthelmentic action. These investigations propose the option of emerging a lead compound of benzotriazole having a potential antifungal activity. Molecular docking simulation based virtual screening with ligand library having benzotriazole derivatives have been performed to identify possible lead molecules to inhibit 1EA1.pdb & 1IYL.pdb receptor for treatment of fungal infection. Further the docked conformation of ligand should be perfectly overlayed with the crystal structure of the downloaded protein. This testing is completed successful and the docked confirmation of the fluconazole is perfectly superimposed with reference structure of fluconazole used by the Autodock docking algorithm.
DOI
https://doi.org/10.22270/jddt.v7i7.1614References
Zhang Y, The Magic Bullets And Tuberculosis Drug Targets, Annu. Rev. Pharmacol. Toxicol, 2005, 537, 38.
Almatarneh MH, Altarawneh M, Poirier RA, Saraireh IA, A high level Ab initio, DFT, and RRKM calculations for the unimolecular decomposition reaction of ethylamine, J. Comp. Sci, 2014, 5, 568-575.
Johnson DR, Lovas FJ, Microwave detection of the molecular transient methyleneimine, Chem. Phys. Lett., 1972, 15, 65–68.
Hamada Y, Hashiguchi K, Tsuboi M, Koga Y, Kondo SJ, Pyrolysis of amines: infrared spectrum of methyleneimine, J. Mol. Spectrosc., 1984, 20,70-80.
Published
Abstract Display: 556 
PDF Downloads: 762 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.